Consensus Target
High Target
Median Target
Low Target
| Date | Analyst | Company | Price Target | News Title |
|---|---|---|---|---|
| 2025-11-14 | Andrew Cooper | Raymond James | $36 | Fulgent Genetics (FLGT) PT Raised to $36 at Raymond James |
| 2025-08-05 | N/A | UBS | $30 | Fulgent Genetics upgraded to Buy from Neutral at UBS |
| 2025-08-04 | N/A | Piper Sandler | $21 | Fulgent Genetics price target lowered to $21 from $23 at Piper Sandler |
| 2025-05-05 | Andrew Cooper | Raymond James | $25 | Fulgent Genetics price target raised to $25 from $24 at Raymond James |
| 2022-12-08 | N/A | Piper Sandler | $40 | Piper Sandler Downgrades Fulgent Genetics to Neutral, Lowers Price Target to $40 |
| 2022-11-18 | N/A | Raymond James | $45 | Raymond James Initiates Coverage On Fulgent Genetics with Outperform Rating, An… |
| 2022-11-14 | N/A | Credit Suisse | $50 | Credit Suisse Maintains Outperform on Fulgent Genetics, Lowers Price Target to … |
| 2022-05-15 | David Westenberg | Piper Sandler | $70 | Fulgent Genetics price target lowered to $70 from $85 at Piper Sandler |